Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D H Ho

Showing results (81-90 of 117) with videos related to

Pageof 12
Sort By:
Clinical Pharmacology and Therapeutics|September 1, 1977
Pharmacologic studies of continuous infusion of arabinosylcytosine by liquid infusion systemD H Ho, N S Brown, J Benvenuto, et al.
Cancer|March 15, 1980
Treatment of cultured human colon carcinoma cells with fluorinated pyrimidinesB Drewinko, L Y Yang, D H Ho, et al.
Chemotherapy|January 1, 1986
Comparative in vitro activity of cefpirome and other antimicrobial agents against isolates from cancer patientsK Rolston, M E Alvarez, J F Hoy, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1984
Clinical pharmacokinetics of aztreonam in cancer patientsP G Jones, G P Bodey, E A Swabb, et al.
Investigational New Drugs|November 1, 1991
Phase I trial of FK973: description of a delayed vascular leak syndromeR Pazdur, D H Ho, K Daugherty, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1986
In vitro activity of BRL 36650, a new semisynthetic penicillinJ F Hoy, K V Rolston, D H Ho, et al.
Cancer Research|December 1, 1972
Cytokinetic and molecular pharmacology studies of arabinosylcytosine in metastatic melanomaJ S Hart, D H Ho, S L George, et al.
Physiological Chemistry and Physics|January 1, 1976
Biological active peptides in human urine: III. Inhibitors of the growth of human leukemia, osteosarcoma, and HeLa cellsS R Burzynski, T L Loo, D H Ho, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 1998
Comparison of 5-fluorouracil pharmacokinetics in patients receiving continuous 5-fluorouracil infusion and oral uracil plus N1-(2'-tetrahydrofuryl)-5-fluorouracilD H Ho, R Pazdur, W Covington, et al.
Anticancer Research|March 1, 1993
Clinical pharmacology of 11-acetyl-8-carbamoyloxymethyl-4-formyl-14-oxa-1,11-diazatetracyclo (7.4.1.0(2,7).0(10,12) tetradeca-2,4,6-trien-6,9-diyl diacetate (FK 973)D H Ho, R Pazdur, N S Brown, et al.
Pageof 12

Showing results (81-90 of 117) with videos related to

Sort By:
Pageof 12
Clinical Pharmacology and Therapeutics|September 1, 1977
Pharmacologic studies of continuous infusion of arabinosylcytosine by liquid infusion systemD H Ho, N S Brown, J Benvenuto, et al.
Cancer|March 15, 1980
Treatment of cultured human colon carcinoma cells with fluorinated pyrimidinesB Drewinko, L Y Yang, D H Ho, et al.
Chemotherapy|January 1, 1986
Comparative in vitro activity of cefpirome and other antimicrobial agents against isolates from cancer patientsK Rolston, M E Alvarez, J F Hoy, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1984
Clinical pharmacokinetics of aztreonam in cancer patientsP G Jones, G P Bodey, E A Swabb, et al.
Investigational New Drugs|November 1, 1991
Phase I trial of FK973: description of a delayed vascular leak syndromeR Pazdur, D H Ho, K Daugherty, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1986
In vitro activity of BRL 36650, a new semisynthetic penicillinJ F Hoy, K V Rolston, D H Ho, et al.
Cancer Research|December 1, 1972
Cytokinetic and molecular pharmacology studies of arabinosylcytosine in metastatic melanomaJ S Hart, D H Ho, S L George, et al.
Physiological Chemistry and Physics|January 1, 1976
Biological active peptides in human urine: III. Inhibitors of the growth of human leukemia, osteosarcoma, and HeLa cellsS R Burzynski, T L Loo, D H Ho, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 1998
Comparison of 5-fluorouracil pharmacokinetics in patients receiving continuous 5-fluorouracil infusion and oral uracil plus N1-(2'-tetrahydrofuryl)-5-fluorouracilD H Ho, R Pazdur, W Covington, et al.
Anticancer Research|March 1, 1993
Clinical pharmacology of 11-acetyl-8-carbamoyloxymethyl-4-formyl-14-oxa-1,11-diazatetracyclo (7.4.1.0(2,7).0(10,12) tetradeca-2,4,6-trien-6,9-diyl diacetate (FK 973)D H Ho, R Pazdur, N S Brown, et al.
Pageof 12